Exchange Announcement • 11 Jun 2024 04:45
Exchange Announcement • 14 May 2024 05:18
Exchange Announcement • 14 May 2024 05:12
Exchange Announcement • 14 May 2024 04:54
Exchange Announcement • 07 May 2024 04:03
𝛼SK or SearchENTITY
Sio Gene Therapies (AXONEUR E1 EQUITY)
Sio Gene Therapies (AXONEUR E1 EQUITY)
3
Analysis
Health Care • United States
Sio Gene Therapies, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops gene therapies that transform the treatment of serious neurodegenerative diseases. Sio Gene Therapies serves customers worldwide.
morex